Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Giacomo Broglio

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Journal of Clinical Medicine|October 14, 2022
Uptake of a Switching Program for Patients Receiving Intravenous Infliximab and Vedolizumab to Subcutaneous PreparationsGemma Burdge, Alice Hardman, Isabel Carbery, et al.
Molecular Aspects of Medicine|February 15, 2024
Recent advances in intestinal fibrosisMarco Vincenzo Lenti, Giovanni Santacroce, Giacomo Broglio, et al.
Internal and Emergency Medicine|July 4, 2023
Role of mucosal immunity and epithelial-vascular barrier in modulating gut homeostasisAntonio Di Sabatino, Giovanni Santacroce, Carlo Maria Rossi, et al.
BMJ Open Gastroenterology|February 22, 2023
Impact on direct and indirect costs of switching patients with inflammatory bowel disease from intravenous to subcutaneous infliximab (CT-P13)Isabel Carbery, Gemma Burdge, Tanya Clark, et al.
Journal of Multimorbidity and Comorbidity|August 27, 2025
Factors associated with comorbidity in hospitalized and non-hospitalized inflammatory bowel disease patients: A single-center, preliminary studyMarco Vincenzo Lenti, Alice Silvia Brera, Giacomo Broglio, et al.
Expert Opinion on Drug Safety|July 7, 2023
Antenatal thiopurine exposure in women with IBD is associated with intrahepatic cholestasis of pregnancyChristian P Selinger, Konstantina Rosiou, Giacomo Broglio, et al.
Digestive Diseases and Sciences|November 27, 2022
Ustekinumab and Vedolizumab Are Equally Safe and Effective in Elderly Crohn's Disease PatientsGerum Gashaw Gebeyehu, Joseph Fiske, Eleanor Liu, et al.
Inflammatory Bowel Diseases|August 3, 2024
Comparative Safety and Effectiveness of Ustekinumab and Anti-TNF in Elderly Crohn's Disease PatientsGerum Gashaw Gebeyehu, Giacomo Broglio, Eleanor Liu, et al.
Frontiers in Gastroenterology (Lausanne, Switzerland)|March 13, 2026
Stigmatization and resilience in inflammatory bowel disease patients at one-year follow-upMarco Vincenzo Lenti, Giacomo Broglio, Caterina Mengoli, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|December 25, 2022
Diagnostic delay in adult coeliac disease: An Italian multicentre studyMarco Vincenzo Lenti, Nicola Aronico, Paola Ilaria Bianchi, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Journal of Clinical Medicine|October 14, 2022
Uptake of a Switching Program for Patients Receiving Intravenous Infliximab and Vedolizumab to Subcutaneous PreparationsGemma Burdge, Alice Hardman, Isabel Carbery, et al.
Molecular Aspects of Medicine|February 15, 2024
Recent advances in intestinal fibrosisMarco Vincenzo Lenti, Giovanni Santacroce, Giacomo Broglio, et al.
Internal and Emergency Medicine|July 4, 2023
Role of mucosal immunity and epithelial-vascular barrier in modulating gut homeostasisAntonio Di Sabatino, Giovanni Santacroce, Carlo Maria Rossi, et al.
BMJ Open Gastroenterology|February 22, 2023
Impact on direct and indirect costs of switching patients with inflammatory bowel disease from intravenous to subcutaneous infliximab (CT-P13)Isabel Carbery, Gemma Burdge, Tanya Clark, et al.
Journal of Multimorbidity and Comorbidity|August 27, 2025
Factors associated with comorbidity in hospitalized and non-hospitalized inflammatory bowel disease patients: A single-center, preliminary studyMarco Vincenzo Lenti, Alice Silvia Brera, Giacomo Broglio, et al.
Expert Opinion on Drug Safety|July 7, 2023
Antenatal thiopurine exposure in women with IBD is associated with intrahepatic cholestasis of pregnancyChristian P Selinger, Konstantina Rosiou, Giacomo Broglio, et al.
Digestive Diseases and Sciences|November 27, 2022
Ustekinumab and Vedolizumab Are Equally Safe and Effective in Elderly Crohn's Disease PatientsGerum Gashaw Gebeyehu, Joseph Fiske, Eleanor Liu, et al.
Inflammatory Bowel Diseases|August 3, 2024
Comparative Safety and Effectiveness of Ustekinumab and Anti-TNF in Elderly Crohn's Disease PatientsGerum Gashaw Gebeyehu, Giacomo Broglio, Eleanor Liu, et al.
Frontiers in Gastroenterology (Lausanne, Switzerland)|March 13, 2026
Stigmatization and resilience in inflammatory bowel disease patients at one-year follow-upMarco Vincenzo Lenti, Giacomo Broglio, Caterina Mengoli, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|December 25, 2022
Diagnostic delay in adult coeliac disease: An Italian multicentre studyMarco Vincenzo Lenti, Nicola Aronico, Paola Ilaria Bianchi, et al.
Pageof 1